SCHEMBL22256808

SCHEMBL22256808

O=C(O)CCC(=O)n1nc(C(=O)Nc2ccc(F)cc2F)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.47
KDM4E B2RXH2 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
LMNA P02545 2/20 0.45
RAB9A P51151 3/20 0.45
THRB P10828 1/20 0.45
ALDH1A1 P00352 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
TAS1R2 Q8TE23 1/20 0.44
NPC1 O15118 1/20 0.43
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 1/20 0.42
ALOX15 P16050 1/20 0.42
GAA P10253 1/20 0.42
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25958318 0.89 FLT1 (0.41) LMNARAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL22256802 0.82 LMNA (0.48) HSD17B10KDM4ERXFP1LMNARAB9A
SCHEMBL22256799 0.82 RAB9A (0.47) HSD17B10KDM4ERXFP1LMNARAB9A
SCHEMBL22939284 0.82 LMNA (0.52) HSD17B10KDM4ERXFP1LMNARAB9A
SCHEMBL22256823 0.82 ALOX15 (0.51) KMT2AALOX15
SCHEMBL22256819 0.81 RAB9A (0.50) HSD17B10KDM4ERXFP1LMNARAB9A
SCHEMBL22939366 0.80 KDM4E (0.47) HSD17B10KDM4ERXFP1LMNARAB9A
SCHEMBL22256785 0.79 RAB9A (0.47) HSD17B10KDM4ERXFP1LMNARAB9A
SCHEMBL22256811 0.78 RAB9A (0.52) HSD17B10KDM4ERXFP1LMNARAB9A
SCHEMBL22256788 0.76 RAB9A (0.49) HSD17B10KDM4ERXFP1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME EMPIRICO INC. 2023-08-10 US disclosed
US-11666588-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same EMPIRICO INC. (US) 2023-06-06 US disclosed
US-11116778-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same EMPIRICO INC. (US) 2021-09-14 US disclosed
US-20210030772-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME EMPIRICO INC. 2021-02-04 US disclosed
WO-2020150265-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME EMPIRICO INC. (US) 2020-07-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME ALOX15, ALOX5, ALOX15B HSD17B10 127/4885KDM4E 1449/4885RXFP1 3948/4885
US-20210030772-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME ALOX15, ALOX5, ALOX15B HSD17B10 127/4885KDM4E 1449/4885RXFP1 3948/4885
US-11666588-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same ALOX15, ALOX5, ALOX15B HSD17B10 127/4885KDM4E 1449/4885RXFP1 3948/4885
US-11116778-B2 Prodrugs of ALOX-15 inhibitors and methods of using the same ALOX15, ALOX5, ALOX15B HSD17B10 127/4885KDM4E 1449/4885RXFP1 3948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.